GlobeNewswire
INmune Bio Announces FDA Alignment on Integrated Phase 2b/3 Registration Pathway for XPro1595 in Early Alzheimer’s Disease
📈
AI Sentiment
Highly Positive
9/10
INmune Bio Inc. News
Latest updates and market news for INMB
3 news
Feb 8 - Feb 14, 2026
Page 1
TipRanks
INmune Bio submits pre-submission package for CORDStrom with MHRA
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
📈
AI Sentiment
Highly Positive
9/10
Share this news page